neuroClues

neuroClues develops accessible, high-speed eye-tracking technology incorporating AI-driven analysis to aid in the diagnosis of neurodegenerative conditions. Their portable headsets capture eye movements at 800 frames per second, providing clinicians with rapid data analysis for conditions like Parkinson's disease. The technology aims to improve diagnostic accuracy and broaden access to objective brain health assessments.

Buy Funded Startups lists

Funding Round: Pre-Series A

Funding Amount: €5M

Date: 30-Apr-2024

Investors: White Fund, European Commission's EIC Accelerator program, Invest.BW, Fiona du Monceau, Artwall, Olivier Legrain

Markets: Medtech, AI, Neuroscience

HQ: Louvain-la-Neuve, Walloon Region, Belgium

Founded: 2020

Website: https://www.neuroclues.com/

LinkedIn: https://www.linkedin.com/company/neuroclues

Twitter: https://twitter.com/neuroClues

Instagram: